4.6 Article

Case report: Cyclophosphamide pulse therapy for chronic recalcitrant erythema nodosum leprosum

Related references

Note: Only part of the references are listed.
Review Biotechnology & Applied Microbiology

Revisited Cyclophosphamide in the Treatment of Lupus Nephritis

Xiao-ying Quan et al.

Summary: Lupus nephritis (LN) is a common complication of systemic lupus erythematosus (SLE), and its pathogenesis involves the deposition of immune complexes in the kidneys. Cyclophosphamide (CY) is the first-line drug for treating LN, and it works by regulating and inhibiting CD4 and CD8 positive T cells.

BIOMED RESEARCH INTERNATIONAL (2022)

Article Medicine, General & Internal

Case Report: A Case Series of Immunobiological Therapy (Anti-TNF-α) for Patients With Erythema Nodosum Leprosum

Ana Flavia Moura Mendes et al.

Summary: Anti-TNF-alpha therapy can be used as an alternative treatment for chronic and severe ENL, reducing the frequency of ENL episodes, immunosuppressive burden, and hospital admissions.

FRONTIERS IN MEDICINE (2022)

Review Infectious Diseases

Experiences of living with leprosy: A systematic review and qualitative evidence synthesis

Norana Abdul Rahman et al.

Summary: This review explores the lived experience of individuals diagnosed with leprosy, the impact of the disease, and how they cope with the burden of the disease. The findings indicate a multi-domain effect on affected individuals, encompassing not only biological and physical effects but also social issues, specific difficulties, emotions, and economic hardships. The way people cope with leprosy is influenced by their interpretation of the disease and its treatment, affecting their help-seeking behavior and adherence to treatment and self-care.

PLOS NEGLECTED TROPICAL DISEASES (2022)

Letter Dermatology

Apremilast in multibacillary leprosy patients with chronic and recurrent erythema nodosum leprosum: a prospective single-centre pilot study

T. Narang et al.

JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY (2021)

Review Public, Environmental & Occupational Health

Biologics in Leprosy: A Systematic Review and Case Report

Anna L. Cogen et al.

AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE (2020)

Article Immunology

Evaluation of monocyte subsets and markers of activation in leprosy reactions

Mayume Shibuya et al.

MICROBES AND INFECTION (2019)

Review Parasitology

Erythema Nodosum Leprosum: Update and challenges on the treatment of a neglected condition

Perpetua do Socorro Silva Costa et al.

ACTA TROPICA (2018)

Review Dermatology

Cyclophosphamide in dermatology

Janet Kim et al.

AUSTRALASIAN JOURNAL OF DERMATOLOGY (2017)

Review Immunology

A Systematic Review of immunological Studies of erythema Nodosum Leprosum

Anastasia Polycarpou et al.

FRONTIERS IN IMMUNOLOGY (2017)

Review Oncology

The effect of cyclophosphamide on the immune system: implications for clinical cancer therapy

Martina Ahlmann et al.

CANCER CHEMOTHERAPY AND PHARMACOLOGY (2016)

Article Psychiatry

Perception of social exclusion, neuropathy, and quality of life among Hansen's disease patients

Roberta Borges-de-Oliveira et al.

INTERNATIONAL JOURNAL OF PSYCHIATRY IN MEDICINE (2015)

Article Infectious Diseases

Viral Co-infection and Leprosy Outcomes: A Cohort Study

Paulo R. L. Machado et al.

PLOS NEGLECTED TROPICAL DISEASES (2015)

Article Psychiatry

Mental disorders in leprosy: An underdiagnosed and untreated population

Clarissa Iris Rocha-Leite et al.

JOURNAL OF PSYCHOSOMATIC RESEARCH (2014)

Article Infectious Diseases

The Mortality Associated with Erythema Nodosum Leprosum in Ethiopia: A Retrospective Hospital-Based Study

Stephen L. Walker et al.

PLOS NEGLECTED TROPICAL DISEASES (2014)

Article Dermatology

Pulse therapy in pemphigus: report of 11 cases

Nurimar Conceicao Fernandes et al.

ANAIS BRASILEIROS DE DERMATOLOGIA (2013)

Review Medicine, General & Internal

Interventions for erythema nodosum leprosum

N. H. J. Van Veen et al.

COCHRANE DATABASE OF SYSTEMATIC REVIEWS (2009)

Letter Medicine, General & Internal

Treatment of recurrent erythema nodosum leprosum with infliximab

William R. Faber et al.

NEW ENGLAND JOURNAL OF MEDICINE (2006)